Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

MHRA: Safety of OTC products containing codeine ‘under review’

The Medicines and Healthcare products Regulatory Agency (MHRA) is keeping the “safety and availability” of codeine-based products “under review”, it has told C+D.

The MHRA will consider the possibility of reclassifying all opioid-based painkillers as prescription-only medicines (POMs) “as necessary”, a spokesperson told C+D last week (March 5).

The medicines regulator was responding to C+D’s question as to whether it would consider reclassifying codeine linctus from a pharmacy (P) medicine to POM, following an increase of enforcement notices placed on pharmacies for the “high purchase numbers of codeine linctus”.

Several regulatory restrictions have already been imposed on over-the-counter (OTC) products containing codeine over the last few years, the MHRA said.

These include recommending the use of OTC painkillers containing codeine and paracetamol, ibuprofen, or aspirin for a maximum of three days.

OTC medicines containing codeine have been limited to 32-tablet pack sizes or less, and they “carry prominent label warnings to highlight the potential for addiction and the fact they contain opioids”, according to the MHRA.

The medicines regulator told C+D it has received “a very small number of queries relating to the OTC status of codeine-containing medicines and is taking these into consideration in its ongoing monitoring of these medicines”.

C+D reported last month that the GPhC had placed conditions on the practice of 38 pharmacies between April 1 last year and January 31, with the majority chastised for “the online, over-the-counter supply of codeine linctus and promethazine-containing medicines”.

Result

Do you think codeine linctus should be reclassified from a P medicine to POM?
Yes
70%
No
15%
N/A, we don't really stock this product anymore
15%
Total votes: 150

Do you regularly supply codeine linctus in your pharmacy?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD007059

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel